Found: 5
Select item for more details and to access through your institution.
Predictive Genetic Biomarkers for the Development of Peritoneal Metastases in Colorectal Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 16, p. 12830, doi. 10.3390/ijms241612830
- By:
- Publication type:
- Article
Adjuvant and first-line palliative chemotherapy regimens in patients diagnosed with periampullary cancer: a short report from a nationwide registry.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-02980-6
- By:
- Publication type:
- Article
Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 9, p. e2124766, doi. 10.1001/jamanetworkopen.2021.24766
- By:
- Publication type:
- Article
Real‐world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 10, p. 1654, doi. 10.1002/ijc.33916
- By:
- Publication type:
- Article